Rivaroxaban for stroke prevention after embolic stroke of undetermined source / Hart, Rg; Sharma, M; Mundl, H; Kasner, Se; Bangdiwala, Si; Berkowitz, Sd; Swaminathan, B; Lavados, P; Wang, Y; Wang, Y; Davalos, A; Shamalov, N; Mikulik, R; Cunha, L; Lindgren, A; Arauz, A; Lang, W; Czlonkowska, A; Eckstein, J; Gagliardi, Rj; Amarenco, P; Ameriso, Sf; Tatlisumak, T; Veltkamp, R; Hankey, Gj; Toni, D; Bereczki, D; Uchiyama, S; Ntaios, G; Yoon, Bw; Brouns, R; Endres, M; Muir, Kw; Bornstein, N; Ozturk, S; O'Donnell, Mj; De Vries Basson, Mm; Pare, G; Pater, C; Kirsch, B; Sheridan, P; Peters, G; Weitz, Ji; Peacock, Wf; Shoamanesh, A; Benavente, Or; Joyner, C; Themeles, E; Connolly, Sj; NAVIGATE ESUS, Investigators; Silvestrini, M. - In: THE NEW ENGLAND JOURNAL OF MEDICINE. - ISSN 0028-4793. - STAMPA. - 378:23(2018), pp. 2191-2201. [10.1056/NEJMoa1802686]
Rivaroxaban for stroke prevention after embolic stroke of undetermined source
Silvestrini MMembro del Collaboration Group
2018-01-01
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
